advanced breast cancer
New Treatment Strategy Proposed for Some Patients With HR-Positive, HER2-Negative Advanced Breast Cancer
SERENA-6 is the first global registration phase 3 trial to demonstrate the clinical utility of ctDNA monitoring to ...
JUNE 16, 2025
Orserdu Approved for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
The FDA has approved Orserdu for postmenopausal women or adult men with estrogen receptor (ER)-positive, ...
FEBRUARY 5, 2023
Load more